Mobius Investment Trust

MMIT has been the top-performing emerging markets trust over its first five years…

Mobius Investment Trust

Mobius Investment Trust (MMIT) invests in small and mid-cap companies across the emerging and frontier-market universes, aiming to generate long-term capital growth and income returns from a highly concentrated portfolio of 20 to 30 stocks.

Mobius Investment Trust - Overview

Mobius Investment Trust (MMIT) invests in small and mid-cap companies across the emerging and frontier-market universes, aiming to generate total returns of 12-15% over the long run from a highly concentrated portfolio of 20 to 30 stocks. The trust is managed by 30-year veteran manager Mark Mobius as well as his former colleague and successor on the Templeton Emerging Markets Investment Trust, Carlos Hardenberg. The managers have a bias towards quality growth stocks which they aim to buy when t

Mobius Investment Trust - Overview

Mobius Investment Trust (MMIT) invests in small- and mid-cap companies across the emerging- and frontier-market universes, aiming to generate total returns of 12–15% over the long run from a highly concentrated portfolio of 20 to 30 stocks. The trust is managed by 30-year veteran manager Mark Mobius as well as his former colleague and successor on the Templeton Emerging Markets Investment Trust Carlos Hardenberg. Greg Konieczny, another former Franklin Templeton workmate, comanaged the trust unt

Mobius Investment Trust - Overview

Mobius Investment Trust (MMIT) invests in small and mid-cap companies across the emerging and frontier market universes, aiming to generate total returns of 12-15% over the long run from a highly concentrated portfolio of 20 to 30 stocks. The trust aims to be highly active and does not have a formal benchmark. The intention is to exploit the inefficiencies in the small-cap markets and to use a “private equity” method of investing. This consists of buying undervalued companies and engaging with

Class of 2018... Update

Last year set new records for the investment trust sector, with launches from Baillie Gifford, Fundsmith and Mobius Capital Partners amongst others adding to assets which reached a record of £189bn by the autumn. We look at the new funds which came to market and examine the progress of the most interesting so far…

Anexo Group (ANX LN) - Solid performance across divisions

Anexo has reported FY23 results, with a solid performance across the Group, boosted by the agreement of its first Emissions action in the year. Increased activity levels in Credit Hire and a large portfolio of claims in Legal Services underpin our forecasts, with the benefit of future Emissions Case agreements providing upside risk should settlements be reached.

AUCTUS ON FRIDAY - 03/05/2024

AUCTUS PUBLICATIONS ________________________________________ ADX Energy (ADX AU)C; target price of A$0.75 per share: Raising new equity to fund a high impact activity programme – ADX has raised A$13.5 mm of new equity priced at A$0.105 per share. One free-attaching option will be issued for evert two placement shares with an exercise price of A$0.15 per share and an expiry date of 08/05/2026. The proceeds from the raise will fund (1) the production testing of the 450 m gas column encountered at

UK's best rated holiday provider: still ~£4 too cheap to us

Hardman & Co Insight: 2023 was an annus horribilis for Quoted UK Infrastructure and Renewable Energy

The focus of Hardman & Co Research is on the nine quoted Infrastructure Investment Companies (IICs) and on the 22 Renewable Energy Infrastructure Funds (REIFs): the stocks analysed are all members of the Association of Investment Companies (AIC). We are updating our publication of January 2023, assessing both the lacklustre share price performances during 2023 and the key issues, including interest rates, inflation and power prices. As a 31-strong group, its combined market capitalisation is no

Hybridan Small Cap Feast - 17 April 24

17th April 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced Dish of the day Admissions: Delistings: What’s baking in the oven? ** Potential**** Initial Public Offerings: Reverse Takeovers: 16 April 2024: Electric Guitar (ELEG.L) Concurrent with its Admission to trading on AIM, Electric Guitar is proposing to acquire the entire issued share capital of 3radi

Hardman & Co Healthcare Index: 2023 – Capital demands dent performance

The Hardman & Co Healthcare Index (HHI) has been running since 2009. Its main function is to highlight the attractions of life sciences investments over the long term. For the second year running, apart from global economic influences affecting world markets, performance in 2023 was dented by the capital-intensive nature of the sector. The HHI fell 3.7%, to 483.8, underperforming the main London markets – FTSE 100 (+3.8%) and FTSE All-Share (3.8%) but outperforming the FTSE AIM All-Share Index (

Avacta Group - FY23 results, Chris Coughlin appointed CEO

Avacta reported results for FY23 but more importantly announced the appointment of Christina Coughlin as CEO wef 1 May, replacing Alastair Smith who is stepping down today. FY23 results were better than consensus at the EPS level. Net cash ended the year at £16.6m, as previously disclosed, which has since been bolstered by the £31m gross equity raise enabling Avacta to fund the AVA6000 programme through Phase 2 clinical trials, as well as advancing other candidates in its pre|CISION™ and Affime

Mining Monthly: March Edition

What you need to know: • Following a long period of consolidation, gold broke out in March, hitting record highs, and continuing to push higher as we enter April. • Silver and copper also had strong months up 10% and 4%, respectively. • More notably, we are finally seeing the equities outperform their underlying metal price with the GDX, SIL, and COPX up 22.7%, 21.1% and 19.4%, respectively, significantly outperforming broader markets. • With precious metals taking the limelight, the rest of the

LIBERUM: Investment Platforms: Initial thoughts on the Dear CEO letter

Braemar - Diversification paying dividends

Braemar’s FY24 trading update was in line with expectations, with revenues of c £150m and underlying operating profit of c £18m. Underlying operations continue to expand and diversify and the company remains well-positioned to drive its future growth strategy. The trading outlook is promising and Braemar should be able to leverage its strong balance sheet in pursuit of strategic growth. We have maintained our underlying estimates for FY24 and FY25, but edge down the valuation based on the lower

Morning Note – 11 March 2024

Morning Note – 26 March 2024

hVIVO - Introducing 2025E; HSD sales grth/margin expansion expected

Post further analysis of the FY 2023 results on 9 April 2024, we are establishing FY 2025 forecasts, as well as modifying our forecast adjusted net profit/EPS figures for 2024 and 2025 to reflect the accounting of the deferred tax asset. Our 2025 forecast calls for 9% growth in customer revenues, stable other operating income (largely R&D tax credits) vs 2024, EBITDA margins going back to the 23% level (after a slight contraction in 2024 to reflect 3 facilities being run in parallel for part of

Unique opportunity in polymer modification

Graft Polymer (UK) PLC (LON:GPL) is focused on the development and commercial production of modified polymers, biological supplements and nano-drug delivery systems. The group was founded in 2017 to commercialise the accumulated technological experience gained through previously implemented project

SHORE CAPITAL - Begbies Traynor Group (BEG) - House Stock at 147p